About Us

TauRx is a global leader in tau-based Alzheimer’s disease research with a mission to discover, develop and commercialise innovative products for the diagnosis and treatment of neurodegenerative diseases caused by protein aggregation. The results of their current late-stage clinical trial, advancing a potential disease modifying treatment for Alzheimer’s Disease, are due to be announced mid-2022. Find out more at www.taurx.com